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Abstract
Background: Albeit exercise is currently advocated as one of the most effective management strategies for
fibromyalgia syndrome (FMS); the implementation of exercise as a FMS treatment in reality is significantly hampered
by patients’ poor compliance. The inference that pain catastrophizing is a key predictor of poor compliance in FMS
patients, justifies considering the alteration of pain catastrophizing in improving compliance towards exercises in
FMS patients. The aim of this study is to provide proof-of-concept for the development and testing of a novel virtual
reality exposure therapy (VRET) program as treatment for exercise-related pain catastrophizing in FMS patients.
Methods: Two interlinked experimental studies will be conducted. Study 1 aims to objectively ascertain if
neurophysiological changes occur in the functional brain areas associated with pain catastrophizing, when
catastrophizing FMS subjects are exposed to visuals of exercise activities. Study 2 aims to ascertain the preliminary
efficacy and feasibility of exposure to visuals of exercise activities as a treatment for exercise-related pain
catastrophizing in FMS subjects. Twenty subjects will be selected from a group of FMS patients attending the
Tygerberg Hospital in Cape Town, South Africa and randomly allocated to either the VRET (intervention) group or
waiting list (control) group. Baseline neurophysiological activity for subjects will be collected in study 1 using
functional magnetic resonance imaging (fMRI). In study 2, clinical improvement in pain catastrophizing will be
measured using fMRI (objective) and the pain catastrophizing scale (subjective).
Discussion: The premise is if exposing FMS patients to visuals of various exercise activities trigger the functional
brain areas associated with pain catastrophizing; then as a treatment, repeated exposure to visuals of the exercise
activities using a VRET program could possibly decrease exercise-related pain catastrophizing in FMS patients.
Proof-of-concept will either be established or negated. The results of this project are envisaged to revolutionize
FMS and pain catastrophizing research and in the future, assist health professionals and FMS patients in reducing
despondency regarding FMS management.
Trial registration: PACTR201011000264179
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Background
Fibromyalgia syndrome (FMS) is arguably one of the
most complex chronic pain conditions to manage [1].
Characterized by widespread musculoskeletal symptoms
and functional disability; FMS is a debilitating condition
which affects millions of people around the world [1].
The significant impact FMS has on quality of life,
society, industry, healthcare systems and state budgets
has rendered FMS a global public health concern [2,3].
Albeit the recent recognition of FMS as a legitimate
condition, the exact aetiology of FMS remains unknown
[1,4]. Finding effective management strategies for FMS
thus continues to frustrate patients and health profes-
sionals [4,5]. Largely based on symptomatic relief, the
management of FMS usually consists of a combination
of pharmacological and non-pharmacological therapies
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[4,5]. With no one intervention found to be superiorly
more effective than the next, FMS management pro-
grams are typically individualized to the patient’s needs
and progressed accordingly [4,5]. Nonetheless, since
most FMS patients display some degree of functional
disability and muscle deconditioning, the current inter-
national consensus is that exercise therapy should at
least be a key component of most FMS management
programs [6,7]. Evidence from clinical trials has reported
that exercise therapy can be beneficial to most FMS
patients and is effective in reducing functional disability
and FMS symptoms [8,9]. For this reason, exercise ther-
apy is currently one of the most advocated management
strategies for FMS [9,10].
The implementation of exercise therapy as a manage-
ment strategy for FMS in reality is however significantly
hampered by poor compliance to exercise programs
among FMS patients [11]. Poor compliance towards exer-
cise and other treatments is a common trait among FMS
patients and is the primary factor contributing to the
chronicity and accelerated deterioration of the condition
[11]. A key predictor of poor compliance towards exer-
cise or activity has recently been identified as pain cata-
strophizing; a cognitive strategy broadly defined as “an
exaggerated negative orientation towards actual or antici-
pated pain experiences” which significantly contributes to
the maintenance of chronic pain [12,13].
Currently, the role of pain catastrophizing is believed to
be more pronounced in FMS than in other rheumatolo-
gic conditions and is recognized as a barrier to the
healthy development of psychological and physical func-
tioning among FMS patients [13,14]. Of concern is that
in FMS patients, the presence of pain catastrophizing
leads to fear-avoidance behaviours which often results in
attrition of physical activity [14]. Inactivity is particularly
detrimental in FMS and typically leads to further compli-
cations such as weakening of the musculoskeletal system,
increased pain, increased fatigue and functional disability
[8-10]. To date, research has focused on identifying the
predictors of poor treatment compliance in FMS, but to
our knowledge there is no research into management
approaches aimed at addressing these predictors and
poor compliance to exercise programs in FMS. The infer-
ence that pain catastrophizing and subsequent fear-
avoidance behaviours may influence the compliance of
FMS patients towards exercise programs, justifies consid-
ering the alteration of pain catastrophizing in the man-
agement of FMS [14,15].
Evidence suggests that cognitive-behavioural therapy,
specifically exposure therapy, may be useful in the altera-
tion of pain catastrophizing [15-18]. Exposure therapy
involves exposing an individual to a task or movement
that he/she fears, until the emotion of fear is alleviated
and disassociated from that particular task or movement
[19]. In improving compliance towards exercise programs
in FMS, the use of exposure therapy is based on the
hypothesis that if patients are repeatedly exposed to
visuals of exercise activities or situations that they report
to catastrophize, pain catastrophizing levels should
decrease over time. The decrease in pain catastrophizing
should ideally lead to a decrease in fear-avoidance beha-
viours, which could fundamentally increase compliance
to the recommended exercise programs. With improved
compliance to exercise programs, FMS patients may be
able to realize the true benefits of exercise and enjoy an
improved quality of life.
Although exposure therapy is traditionally conducted
during real situations (in vivo exposure therapy) or during
an imagined situation (imagined exposure therapy), more
recent innovations indicate that exposure therapy can also
be administered via virtual reality technology, namely vir-
tual reality exposure therapy (VRET) [20,21]. VRET is a
type of exposure therapy in which the user can be
immersed into a computer-generated environment via a
head-mount display and exposed to a simulation of a spe-
cific feared situation [20,21]. Contrary to other types of
exposure therapy, VRET seems ideal for conditions where
the real situations are inaccessible or costly (in vivo expo-
sure) or individuals find it difficult to imagine various
situations (imagined exposure therapy) [20,21]. To date,
VRET has successfully been used for other forms of pho-
bias, such as fear for spiders and flying, but has never been
used in the treatment of fear of movement/exercise, nor
pain catastrophizing in chronic pain conditions.
The previous postulation that imagined exposure ther-
apy may effectively reduce pain catastrophizing in FMS
patients makes the investigation of VRET as a treatment
for pain catastrophizing in FMS a plausible option [17].
However, since no VRET program for the treatment of
pain catastrophizing in FMS patients currently exists;
preliminary steps are required prior to the development
and testing of such a program. Initially, it has to be ascer-
tained if visual exposure to catastrophized exercise activ-
ities cognitively triggers the functional brain areas
associated with pain catastrophizing. The premise is that
if visual stimuli of the catastrophized exercise activities
cognitively trigger pain catastrophizing in the associated
functional brain areas; graded and repeated exposure to
visuals of the catastrophized exercise activities using a
VRET program could possibly decrease pain catastro-
phizing and subsequently decrease fear to movement,
essentially improving compliance towards exercise ther-
apy programs among FMS patients. If the results of this
proof-of-concept study are positive, this scientific break-
through in FMS research will enable FMS sufferers to
engage in beneficial physical activity without fear and
possibly improve their quality of life. The following pro-
tocol presents the details of a project which aims to
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provide proof-of-concept for the further development
and testing of a novel VRET program as treatment for
exercise-related pain catastrophizing in FMS patients.
Methods
Ethical approval for this study was obtained from the
Health Research Ethics Committee of the Stellenbosch
University during July 2010. Permission to conduct the
study at the various study centres was granted by the
various departmental heads. All eligible subjects will be
required to read and sign an informed consent form
before participating in this study. A unique study identi-
fication number/code will be allocated to subjects as
they are entered into the study, thereby maintaining
anonymity of all study participants. Confidentiality of
participant’s information will be maintained throughout
the study process by storing the study data in a locked
facility accessible only to the study personnel.
Description of the overall project
The proposed project will consist of two interlinked
experimental studies: Study 1 and Study 2.
Study 1 will incorporate an observational within-sub-
ject study design and aims to ascertain the neurophysio-
logical changes occurring in the functional brain areas
associated with pain catastrophizing when catastrophiz-
ing FMS patients are exposed to various visuals of exer-
cise activities. Functional magnetic resonance imaging
(fMRI) will be used to observe these neurophysiological
changes within the associated functional brain areas.
Study 1 will be conducted at the Cape Universities Brain
Imaging Centre (CUBIC) situated at the Stellenbosch
University’s Tygerberg medical campus in Cape Town,
South Africa (SA).
Study 2 will incorporate a quasi-, within-subject/
between-groups experimental (pre- and post-, with/
without treatment) study design and aims to ascertain
the preliminary efficacy of visual exposure to exercise
activities on pain catastrophizing in FMS patients. Clini-
cal improvement in pain catastrophizing will be mea-
sured using objective and subjective outcome measures.
The feasibility of using visual exposure to exercise activ-
ities as a treatment for pain catastrophization experi-
enced by FMS patients in terms of: 1) time taken to
administer; 2) ease of use; 3) safety of administration; 4)
participant acceptability; and 5) participant opinion/
thoughts of the intervention, will also be ascertained.
Study 2 will be conducted at the Body in Motion analy-
sis lab at the Stellenbosch University’s Tygerberg medi-
cal campus in Cape Town, SA.
It is envisaged that the data collection period of the
project will commence in June/July 2011 and be com-
pleted by September/October 2011.
Study population and recruitment process
Twenty eligible subjects will be conveniently sampled
from the available FMS population currently registered
at the Tygerberg Hospital (TBH) Rheumatology clinic
and/or attending the monthly FMS group meetings held
at the TBH Occupational therapy (OT) department. The
rheumatologists and/or occupational therapist working
in the TBH Rheumatology clinic and/or OT department
will be asked to identify all new or previously diagnosed
FMS patients attending the clinic. The principle
researcher and research assistant(s) will approach all
potential patients personally or telephonically, and invite
them to participate in the study. In addition, the clinic’s
patient database will be manually searched for all poten-
tial patients who have been diagnosed with FMS, but no
longer attend the monthly meetings or the clinic. All
potential patients listed on the database for whom con-
tact details are available will be contacted telephonically
and invited to participate in this project.
Study outcomes
Study outcomes will include subjective and objective
measures. Subjective measures will include pain cata-
strophizing, as measured using the Pain catastrophizing
scale (PCS) and fear-avoidance behaviours/kinesiopho-
bia, as measured using the Tampa scale of Kinesiopho-
bia (TSK). The PCS is a self-report measure which
includes 13 items about the thoughts and feelings experi-
enced when an individual is in pain. Respondents use a
5- point rating scale (where 0 = never to 4 = always), to
indicate how often they experience each thought/feeling.
The total score for the PCS equals 52, with a score above
24 indicating a high score. High internal reliability
(alpha coefficient for total pain catastrophizing scale =
0.87) has been reported in patients with chronic pain
with adequate validity and test-retest reliability [12].
The TSK is a self-report instrument designed to assess
fear of pain and activity. It consists of 17 items each
rated on a 4-point Likert scale. The total score for the
TSK equals 68. Responses are summed to create a total
score, with higher scores (above 37) indicating greater
fear of pain and activity. The scale has demonstrated
test-retest reliability and internal consistency (Cronbach
alphas have ranged 0.68 to 0.80) in studies of patients
with chronic low back pain. Stability over time and the
criterion validity and construct validity has been pre-
viously established [22].
Objective measures will include neurophysiological
changes, as measured using the Siemens MAGNETOM
Allegra 3 Tesla fMRI scanner available at the CUBIC
facility. The Allegra 3 Tesla fMRI scanner is a dedicated
brain scanner and currently the most advanced brain
imaging instrument on the market [23].
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Subject inclusion and exclusion criteria
Adult male and female subjects aged 18 years and older,
who have been clinically diagnosed with FMS according
to the American College Rheumatology (ACR) criteria
[24] by a qualified rheumatologist; subjectively display
high PCS (more than 24 points) and TSK (more than 37
points) scores, and are registered as a patient at TBH
Rheumatology clinic/OT department, will be included in
this study. Subjects diagnosed with other conditions not
related to FMS i.e. cancer; who have severe physical dis-
abilities; who suffer from chronic rheumatoid conditions
i.e. systemic lupus erythmatosus and rheumatoid arthri-
tis; who have previously been hospitalized for a major
psychiatric disorder; who have an uncontrolled endo-
crine or allergic disorder; who are using medication
other than the prescribed pharmacologic agents for FMS
symptoms; who have been using any narcotics long-
term; who currently or who have previously abused any
illicit substances or alcohol; have been diagnosed with
epilepsy, or other conditions contraindicated in the use
of visual exposures to stimuli; who display any contrain-
dications which prohibit the use of fMRI, i.e. cardiac
pacemakers, metal implants, claustrophobia, pregnancy
and cochlear implants; and who are unable to discon-
tinue intake of anti-depressants 4 weeks prior to com-
mencement of study, will be excluded from this study.
Allocation to study groups
On consenting to participate in this project, subjects will
be randomly allocated into Group A (VRET/intervention
group) or Group B ("waiting list"/control group) using a
computer-generated random number sequence con-
structed by an independent statistician. Allocation will
be concealed in opaque envelopes containing the letters
‘A’ or ‘B’ and administered by an independent individual
not part of the study. Study procedures will be thor-
oughly explained to each subject. Sociodemographic
forms, the General Practice Physical Activity Question-
naire (GPPAQ), and the Revised Fibromyalgia Impact
Questionnaire (FIQR) will be administered to each sub-
ject at the beginning of study 1. GPPAQ is a validated
screening tool for use in primary care to assess adult (16
- 74 years) physical activity levels [25]. It provides a sim-
ple 4-level physical activity index, categorizing patients
as inactive, moderately inactive, moderately active and
active. The FIQR is an updated version of the Fibromyal-
gia Impact Questionnaire (FIQ) that has good psycho-
metric properties, can be completed in less than 2
minutes and is easy to score. It has scoring characteris-
tics comparable to the original FIQ, making it possible to
compare past FIQR results with future FIQR results [26].
The FIQR assesses level of functioning. The original FIQ
was developed and validated by Burckhardt et al (1991)
to assess the current health status of women with FMS
[27].
Study groups will progress as a cluster group from
study 1 to study 2 to reduce the period of time between
baseline scans and final post-intervention/control scans.
Study procedures
Study 1: A neurophysiological analysis (fMRI scan) will
be scheduled at a time most convenient for Group A and
B subjects. Transport/remuneration for transport will be
provided to and from the study venue on the day of the
subject’s scheduled appointment. On the day of the
scheduled neurophysiological analysis, subjects will again
be informed of the fMRI procedure and asked to comply
with all the regulations of the laboratory. This prepara-
tion session will be conducted in the MRI simulation
room situated within CUBIC facility. A set of the PCS
and TSK will be administered prior to the commence-
ment of the fMRI session and used as baseline data. Sub-
jects will be escorted to the MRI room and asked to lie
down inside the fMRI chamber. Foam cushions will be
used to immobilize the head. The subjects will be
required to wear MRI compatible earmuffs for communi-
cation with the experimenter and to minimize scanner
noise. For structural localization, a MEMPRAGE struc-
tural sequence with a spatial resolution of 1 × 1 × 1 mm3
will be acquired (approx 9 minutes) for each subject. The
tasks/stimuli used in the MRI sequence have been
derived from other cognitive-behavioural therapy studies
[15-17], but have been modified for application in this
study. The tasks/stimuli have been specifically and care-
fully chosen and designed so as to elicit pain catastro-
phizing in the FMS subjects. The tasks/stimuli, although
different, are also somewhat similar in concept/idea, so
that they do not elicit completely different neurophysio-
logical activity responses. The following tasks/stimuli will
be applied during the fMRI scanning: 1) Visuals of exer-
cise/physical activities (30s clips of various exercise activ-
ities) (4 minutes); 2) Visuals of everyday sedentary
activities (i.e. 30s clip of reading a book/magazine) (4
minutes); and 3) Verbal visualization (30s of standardized
verbal instruction where subject is instructed to imagine
an activity i.e. running, cycling, skipping, etc.) (4 min-
utes). The fMRI sequence which entails the application
of the three tasks/stimuli will last approximately 12 min-
utes and consist of 3 runs. The application of each of the
three tasks/stimuli will constitute one run. Each run will
last approximately 240 seconds (s) and comprises of: 4 ×
30s ‘off’ periods (no stimulus) and 4 × 30s ‘on’ periods
(stimuli). The order of the stimuli/’off’ periods will be
randomized using a coin-tossing procedure. In total,
from preparation to completion, the MRI procedure
for each subject will last approximately 40 minutes
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(15 minutes preparation + 9 minutes MEMPRAGE scan
+ 12 minutes MRI task ± 4 minutes extra).
Study 2: On completing baseline scans in study 1,
group B subjects (n = 10) will be instructed to complete
another set of the PCS and TSK and continue daily activ-
ities as normal for the next eight weeks (control group).
No other education/treatment/information will be given
to group B subjects. Appointments to return to CUBIC
for final scans after eight weeks will be scheduled for
group B subjects. On completing baseline scans in study
1, one-hour long sessions will be scheduled for group A
subjects (n = 10) twice a week for eight weeks (interven-
tion group). During the twice weekly treatment sessions,
subjects will be placed in an isolated room and be
exposed to visuals of various exercise activities. Visual
exposure to exercise activities will be delivered via a VR
head-mount display (HMD); namely the eMagin Z800
3DVISOR linked to an ASUS K61IC series laptop. The
eMagin Z800 3DVISOR has a highly sophisticated built-
in head tracker which allows the user six degrees of free-
dom in motion [28]. The HMD is placed on the head of
the user, blocking off the surrounding environment. The
visuals relayed to the HMD via a connected laptop are
viewed on two 3D OLED 0.59 inch micro displays, which
to the user seem to play as huge as a 105-inch screen.
These specific features of the eMagin Z800 3DVISOR
enhance the immersion of the user into the virtual envir-
onment [28]. Software will consist of an hour-long DVD
comprised of various simulated exercise activities. The
subject may only be accompanied by a research assistant
or translator. The PCS and TSK will be administered
before and after each session. Information relating to the
feasibility and logistics of the study will be collected from
Group A’s subjects at the end of the eight-week treat-
ment program.
The PCS and TSK will be administered before and
after the eight week time period for both groups. No
PCS and TSK scores will be collected during the eight
weeks for group B’s subjects. At the end of the eight-
week study period, both groups will undergo final fMRI
scans.
• Feasibility and logistics
To determine the feasibility of the intervention and
logistics of the procedure, the following information will
be recorded using a datasheet which will include a post-
treatment survey: time it takes to explain the procedure,
equipment, visuals, etc. to the participant; time it takes
the participant to familiarize himself with the equip-
ment; time it takes to set-up the equipment; time it
takes to administer the exposure session; any adverse
effects due to intervention; ease of using the equipment;
subject’s acceptability and opinions/thoughts of using
the equipment.
• Loss to follow-up
Should subjects not be able to handle being exposed to
the visual of the exercise activities, he/she will be
allowed to stop the exposure therapy treatment and
carry on at a later stage. Should the subject refuse to
participate any longer, data will be retained regardless as
to how many sessions were completed and analyzed
accordingly. All reasons for termination or suspension
of treatments will be documented.
Data collection and storage
The research assistant will document the randomized
order of the stimuli/’off’ periods during each run for
each subject on a simple datasheet. This information
will be blinded from the rest of the research team. Neu-
rophysiological changes occurring during the fMRI
sequence will be recorded and standard MEMPRAGE
and EPI BOLD sequences will be acquired. fMRI data
for each subject will be saved and stored on two hard-
drives, under the reference number allocated to that
subject. A research assistant will administer and collect
completed PCS, TSK, GPPAQ and FIQR questionnaires,
as well as sociodemographic forms from subjects. Data
collected will be stored in the subject’s respective
folders. Back-up files of all data will be made and stored
in a separate location. Folders, data and back-up data
will be stored in a locked room with controlled access
at all times. All subject identification and information
will be kept confidential.
Statistical analysis
Study 1: fMRI data acquired from the subjects will be
analyzed by a blinded radiologist or physiologist. The
principle researcher will be involved in the analysis of
the data. Contrasts between the different sets of data
will be analyzed using Oxford’s FMRIB Software Library
(FSL), which is currently available at CUBIC. FSL is a
collection of functional and structural brain image ana-
lysis tools, written by members of the Image Analysis
Group at the Oxford Centre for Functional Magnetic
Resonance Imaging of the Brain (FMRIB), Oxford Uni-
versity. FSL is distributed as freeware and most of the
tools can be run both from the unix command line and
as a graphical user interface [29]. Single-subject analyses
will be performed by linear regression of the fMRI data.
The functional brain regions to be analyzed and com-
pared will include the areas previously associated with
pain catastrophizing namely: the secondary somatosen-
sory cortex (SII), contralateral insula, primary somato-
sensory cortex (SI), inferior parietal lobule and
thalamus, contralateral anterior ACC, the contralateral
and ipsilateral lentiform activation in SI, anterior and
posterior cerebellum, posterior cingulate gyrus, and
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superior and inferior frontal gyrus [30]. The scans will
be registered to high resolution Montreal Neurological
Institute (MNI) structural scans so that the FSL grey
matter atlas tools can be used to correctly locate the
regions of interest.
Study 2: Mean pre- and post-session (intervention
group), as well as mean pre- and post-treatment (inter-
vention and control group) PCS and TSK scores will be
analyzed and compared between the groups and within-
subjects for preliminary efficacy of the intervention.
Paired t test for comparison of two dependent samples
and contrast for the significance of the Pearson r correla-
tion between two quantitative variables will be assessed.
The open-ended questions of the post-treatment survey
will be qualitatively analyzed and the closed-ended ques-
tions will be quantitatively analyzed using frequency
counts. Post-intervention fMRI data will be analyzed and
compared to subject fMRI data obtained at baseline. Sin-
gle-subject analyses will be performed by linear regres-
sion of the fMRI data.
Discussion
The premise is if visuals of various exercise activities trig-
ger the functional brain areas associated with pain cata-
strophizing in FMS subjects; then as a treatment, it can
be postulated that graded and repeated exposure to
visuals of exercise activities using a VRET program could
possibly decrease pain catastrophizing and subsequently
decrease fear to movement, essentially improving compli-
ance towards exercise therapy programs among FMS
patients. Proof-of-concept for the development and test-
ing of a novel VRET program for exercise-related pain
catastrophizing in FMS will either be established or
negated. The results of this project are envisaged to revo-
lutionize FMS and pain catastrophizing research and in
the future, assist health professionals and FMS patients
in reducing despondency regarding FMS management.
Acknowledgements
The authors would like to acknowledge the following people for their
expertise, guidance and assistance: Drs M. Manie, R. Du Toit, D. Whitelaw
and the rest of the staff working at the TBH Rheumatology clinic; Ms T.
Ahmed and Mrs. R. Pillay working at the TBH OT department; Ms K.
Theunissen and Ms J. Koep; and Mrs. L. Klein at the CUBIC facility. The
authors would also like to thank the following institutions for funding this
ongoing project: the Harry Crossley Foundation, the National Research
Foundation and the Stellenbosch University.
Stopping rules
The study will be stopped in the event of protocol being violated in any way.
Independent data-monitoring committee
Currently, the Heath Research Ethics Committee of the Stellenbosch
University serves as the independent data-monitoring committee and will
ensure that all data collected is authentic and that data is handled and
reported appropriately.
Author details
1Division of Physiotherapy, Faculty of Health Sciences, Stellenbosch
University, Tygerberg, 7505, South Africa. 2Centre for Allied Health Evidence,
University of South Australia, Adelaide, Australia. 3MRC/UCT Medical Imaging
Research Unit, Department of Human Biology, University of Cape Town and
Department of Radiology, Stellenbosch University, Tygerberg, South Africa.
Authors’ contributions
LDM conceptualized the project idea and study design and drafted the
project proposal manuscript in preparation for publication submission. KAGS
and QAL assisted in refining the project idea and study design and in
drafting the final manuscript. BS provided the technical information relating
to fMRI and assisted in refining the study design. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 12 November 2010 Accepted: 30 April 2011
Published: 30 April 2011
References
1. Goldenberg D: Introduction: Fibromyalgia and its related disorders. J Clin
Psychiatry 2008, 69.
2. Annemans L, Le Lay K, Taïeb C: Societal and patient burden of
fibromyalgia syndrome. Pharmacoeconomics 2009, 27(7):547-59.
3. Lachaine J, Beauchemin C, Landry PA: Clinical and economic
characteristics of patients with fibromyalgia syndrome. Clin J Pain 2010,
26(4):284-90.
4. Boomershine C, Crofford L: A symptom-based approach to pharmacologic
management of fibromyalgia. Nat Rev Rheumatol 2009, 5:91-199.
5. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F: Treatment strategy
in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum
2008, 37(6):353-65.
6. Jones K, Liptan G: Exercise Interventions in Fibromyalgia: Clinical
Applications from the Evidence. Rheum Dis Clin N Am 2009, 35:373-391.
7. Williams A, Clauw D: Understanding Fibromyalgia: Lessons from the
Broader Pain Research Community. Pain 2009, 10(8):777-791.
8. Kelley G, Kelley G, Hootman J, Jones D: Exercise and global well-being in
community-dwelling adults with fibromyalgia: a systematic review with
meta-analysis. BMC Public Health 2010, 10:198.
9. Häuser W, Klose P, Langhorst J, Moradi M, Steinbach M, Shiltenwolf M,
Busch A: Efficacy of different types of aerobic exercise in fibromyalgia
syndrome: a systematic review and meta-analysis of randomised
controlled trials. Arthritis Res Ther 2010, 12:R79.
10. Richards S, Scott D: Prescribed exercise in people with fibromyalgia:
parallel group randomised controlled trial.Bmj.com. 2002, 325:185.
11. Oliver K, Cronan T: Predictors of Exercise Behaviors among Fibromyalgia
Patients. Prev Med 2002, 35:383-389.
12. Sullivan M, Bishop S, Pivik J: The pain catastrophizing scale: development
and validation. Psychol Assess 1995, 7:524-532.
13. Edwards R, Bingham C, Bathon J, Haythornethwaite J: Catastrophizing and
Pain in Arthritis, Fibromyalgia, and Other Rheumatic Diseases. Arthritis
Rheum 2006, 55(2):325-332.
14. Hassett A, Cone J, Patella S, Sigal L: The role of catastrophizing in the pain
and depression of women with fibromyalgia syndrome. Arthritis Rheum
2000, 43(11):2493-500.
15. Nelson P, Tucker S: Developing an Intervention to Alter Catastrophizing
in Persons with Fibromyalgia. Orthop Nurs 2006, 25:3.
16. Garcia-Campayo J, Serrano-Blanco A, Rodero B, Magallon R, Alda M,
Andres E, Luciano J, del Hoyo Y: Effectiveness of the psychological and
pharmacological treatment of catastrophization in patients with
fibromyalgia: a randomized controlled trial. Trials 2009, 10:24.
17. Rodero B, Garcia-Campayo J, Fernandez B, Sobradiel N: Imagined exposure
as treatment of catastrophizing in fibromyalgia: a pilot study. Actas Esp
Psiquiatr 2008, 36(4):223-226.
18. van Koulil S, Effting M, Kraaimaat F: Cognitive-behavioural therapies and
exercise programmes for patients with fibromyalgia: state of the art and
future directions. Ann Rheum Dis 2007, 66:571-581.
19. [http://www.minddisorders.com/Del-Fi/Exposure-treatment.html], (accessed
May 2010).
20. Parson T, Rizzo A: Affective outcomes of virtual reality exposure therapy
for anxiety and specific phobias: A meta-analysis. J Behav Ther Exp
Psychiatry 2008, 39:250-261.
Morris et al. BMC Musculoskeletal Disorders 2011, 12:85
http://www.biomedcentral.com/1471-2474/12/85
Page 6 of 7
21. Powers M, Emmelkamp P: Virtual reality exposure therapy for anxiety
disorders: A meta-analysis. J Anxiety Disord 2008, 22:561-569.
22. Roelofs J, Goubert L, Peters M, Vlaeyen J, Crombez G: The Tampa scale for
Kinesiophobia: further examination of psychometric properties in
patients with chronic low back pain and fibromyalgia. European J Pain
2004, 8:495-502.
23. [http://www.sun.ac.za/cubic], (Accessed May 2010).
24. Staud R: Fibromyalgia pain: Do we know the source? Curr Opin Rheumtol
2004, 16:157-163.
25. Physical Activity Policy, NHS. 2009.
26. Bennett R, Friend R, Jones K, Ward R, Han B, Ross R: The Revised
Fibromyalgia Impact Questionnaire: validation and psychometric
properties. Arthritis Res Ther 2009, 11.
27. Burckhardt CS, Clark BD, Bennett RM: The fibromyalgia impact
questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
28. [http://www.emagin.com], (accessed May 2010).
29. Smith S, Jenkinson M, Woolrich M, Beckmann C, Behrens T, Johansen-
Berg H, Bannister P, De Luca M, Drobnjak I, Flitney D, Niazy R, Saunders J,
Vickers J, Zhang Y, De Stefano N, Brady J, Matthews P: Advances in
functional and structural MR image analysis and implementation as FSL.
Neuroimage 2004, 23:208-219.
30. Gracely R, Geisser M, Giesecke M: Pain catastrophizing and neural
responses to pain among persons with fibromyalgia. Brain 2004,
127:835-843.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/12/85/prepub
doi:10.1186/1471-2474-12-85
Cite this article as: Morris et al.: Virtual reality exposure therapy as
treatment for pain catastrophizing in fibromyalgia patients: proof-of-
concept study (Study Protocol). BMC Musculoskeletal Disorders 2011 12:85.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Morris et al. BMC Musculoskeletal Disorders 2011, 12:85
http://www.biomedcentral.com/1471-2474/12/85
Page 7 of 7
